OncoDaily Newsletter

Subscribe to our newsletter

Subscribe

Sharlene Gill: Reflecting on Top 5 Trial Takeaways from ESMOGI26

A Partnership to Deliver Life-Saving Cancer Care for Children, Regardless of Where They Are Born - KHCF/KHCC

Shane Jacobson: One of the Best Parts of Being CEO of ACS and ACS CAN

We Are Only Here to Help... Hear from Cancer Survivors

Oncology News, Insights, Stories by OncoDaily

COMPASS
Immune Oncology

COMPASS: Can AI Predict Immunotherapy Response Across Multiple Cancers?

GU Oncology
Genitourinary Oncology

10 Must-Read Posts In GU Oncology This Week

Pramesh CS
Voices

Pramesh CS: Every Great Research Career Has a Defining Moment. CReDO Could Be Yours

Princess Ghida Talal: Opening of New Breast Cancer Early Detection Headquarters

Claude Science: What Anthropic's New Research Workbench Actually Does for Oncology

10 Must-Read Posts in Radiotherapy This Week: June 28 - July 5

Monica Bertagnolli Begins Her Presidency in the National Academy of Medicine

This Independence Day, Take Back Your Health - Secretary Kennedy on July 4th

State of Michigan Invests $1 Million in YesRx to Provide Free Life-Saving Cancer Medication

AACR and AAMC CEOs Call to Action Against Federal Proposal That Could Severely Weaken US Research Grants

Voices
Don S. Dizon

Don S. Dizon: Clinical Equipoise and the Challenge of Personalizing Care

Caroline Chung: Why Cancer Care’s Next Chapter Depends on Culture, Data, and Precision

Bella Van Sebille: Excited to Advance Supportive Cancer Care in Australia Through Collaboration

Nicole Stout: Why We Cannot Wait for Cancer Patients to Ask for Supportive Care

Kandice McLeod: Proud to Celebrate the Hematology/Oncology Fellowship Class of 2026

Ted Okon: 340B Discounts Should Go to Patients in Need, Not Wealthy Hospital Systems

Wafaa M Rashed: Expressing Our Appreciation to OncoDaily for Supporting PAPERI

FDA Approvals
FDA belzutifan plus pembro for RCC

FDA Approves Belzutifan Plus Pembrolizumab for Adjuvant RCC

FDA Approved Decnupaz (pivekimab sunirine-pvzy), the First ADC for Adults With BPDCN

FDA Approves FoundationOne CDx as Companion Diagnostic for TEPMETKO in METex14 NSCLC

FDA approved Atezolizumab for adjuvant treatment of MDR–positive MIBC

FDA Grants Approval for Oral Decitabine/Cedazuridine With Venetoclax in Newly Diagnosed AML

FDA Greenlit New Pancreatic Cancer Drug Daraxonrasib For Expanded Access

FDA Grants Full Approval of Tecartus for Relapsed/Refractory Mantle Cell Lymphoma in Adults

OncoDaily 100
100 influential survivors

100 Influential Cancer Survivors on Social Media: 2026 Edition

100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2025

The 100 Most Influential CEOs in Oncology in 2025 (Full List)

The 100 Most Influential People in Oncology in 2025 (Full List)

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025

100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2024

Top 100 Xfluencers in Lung Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024

Celebrities and Cancer

OncoCalendar

Managing Early T-Cell Precursor ALL: A Case-Based Discussion by Resonance

Resonance

10 Jul
Resonance

ESSO Advanced Course on the Treatment of Peritoneal Surface Malignancy

European Society of Surgical Oncology

15 Oct
Peritoneal Surface Malignancy

ESSO Hands-On Course on the Minimally Invasive Management of Peritoneal Surface Malignancies

European Society of Surgical Oncology

15 Sep
Peritoneal Surface Malignancies

ESO-ESSO-ESTRO-ESP Multidisciplinary Course on Oncology for Medical Students

European Society for Radiotherapy and Oncology (ESTRO)

24 Aug
Oncology

ESO Ambassador Event on Neoadjuvant and Post-Neoadjuvant Treatment in Breast Cancer

European School of Oncology (ESO) College

30 Oct
Breast Cancer

Immune-oncology
10 Must-Read Posts in Immuno-Oncology This Week

10 Must-Read Posts in Immuno-Oncology This Week

Immunotherapy and Summer Sun: What Patients Should Know About Skin Safety, Baths, and Heat

COMPASS: Can AI Predict Immunotherapy Response Across Multiple Cancers?

STAR-221 at ESMO GI 2026: Domvanalimab Plus Zimberelimab in HER2-Negative Advanced Gastric Cancer

Neo-CheckRay Trial: Can Radiotherapy Turn Immune-Cold Breast Cancer Into an Immunotherapy Target?

FDA Approves Tregzi, the First Regulatory T-Cell Therapy for Allogeneic HSCT

RECLAIM Trial: Can Radiotherapy Restore Immunotherapy Sensitivity?

Gastrointestinal-Oncology
TROP2

TROP2 Emerges as a Therapeutic Target in Colorectal Cancer Cell States Linked to Metastasis and Resistance

BOT/BAL Shows 33% 3-Year OS in Refractory MSS mCRC Without Active Liver Metastases

Agenus Reports Landmark 3-Year OS Data for BOT+BAL in Refractory MSS mCRC at ESMO GI

TOURMALINE: Durvalumab Plus Gemcitabine-Based Chemotherapy in Advanced BTC

Wungki Park: The Future of Pancreatic Cancer Has Never Looked Brighter

Ivane Kiladze: Rewarding Combination of Learning, Running and Collaboration at ESMO GI 2026

Nehemias Guevara Rodriguez: Promising Second Line Strategy for Advanced Hepatocellular Carcinoma

Breast-Oncology
Breast Cancer

Can Routine Pathology Slides Improve Breast Cancer Risk Assessment?

FDA Approvals for Metastatic TNBC: 2 New Options Explained

NeoCarbo Study: Can HRD Identify Triple-Negative Breast Cancers More Likely to Respond to Platinum-Based Neoadjuvant Therapy?

Lumpectomy Margin Width and Local Recurrence in DCIS: Findings From NSABP B-35

Can HER2DX Help Refine Neoadjuvant Treatment in Early HER2-Positive Breast Cancer?

Trastuzumab Rezetecan Extends Progression-Free Survival in Previously Treated HER2-Positive Metastatic Breast Cancer

Oral SERDs Are Redefining Endocrine Therapy in HR-Positive, HER2-Negative Breast Cancer

Lung-Oncology
Tarlatamab

Severe Neurotoxicity After Tarlatamab in SCLC Brain Metastases: Could It Be TIAN Rather Than ICANS?

Roche Reports Positive Phase 3 Results for Divarasib in Previously Treated KRAS G12C NSCLC

Could Proton Pump Inhibitors Affect Durvalumab Outcomes After Chemoradiotherapy in Stage III NSCLC?

KRASG12C Inhibitors in NSCLC Brain Metastases: Why Intracranial Control Still Requires More Than Monotherapy

New Analysis Challenges the Claim That COVID-19 mRNA Vaccines Improve Immunotherapy Outcomes

Improving Neoadjuvant and Perioperative Therapy in Resectable NSCLC: Moving Beyond a One-Size-Fits-All Approach

TP53 Gain-of-Function Mutations May Signal Early Osimertinib Resistance in EGFR-Mutant NSCLC

Oncology Tech
Claude Science

Claude Science: What Anthropic's New Research Workbench Actually Does for Oncology

Is the First AI-Designed Cancer Drug About to Be Approved?

AI Meets the Brain: Inside Insilico and SK Biopharmaceuticals’ $2.5 Billion Neuroimmune Bet

Inside DeepHealth: How RadNet's AI Bet Is Reshaping the Business of Radiology

A Solid-Tumor First: What China's Landmark CAR-T Approval Means for the Cell-Therapy Industry

Merck KGaA's $11.3 Billion Bet on Bio-Techne Redraws the Map of Life-Science Tools

FDA Approves Gilead’s Trodelvy, Alone and With Merck’s Keytruda, in First-Line Metastatic TNBC

Hematology
MCL, ibrutinib, ASCT

Phase 3 TRIANGLE: Reassessing the Role of ASCT in Frontline Ibrutinib-Containing Therapy for MCL

Mantle Cell Lymphoma (MCL): Revealing the Biology Beneath the Mantle and Modern Therapeutic Frontiers

Phase 3 PERSPECTIVE: Frontline Ibrutinib + Rituximab Extends PFS in CIT-Ineligible Follicular Lymphoma

Spatial and Multi-Omics Reveal Pericyte-Derived CCL19 as an Adverse Prognostic Factor in CNS Lymphoma

High-Dose Methotrexate Does Not Reduce CNS Relapse Risk in Ultra High-Risk LBCL: An International Analysis

Burkitt Lymphoma: Among the Fastest Growing Yet Most Curable Human Cancers

Blood Cancers in Women: Fertility After Treatment and Cancer During Pregnancy

Radiotherapy
ESTRO

ESTRO Sets Practical Guidance for Focal Boosting in Prostate Cancer Radiotherapy 2026

10 Must-Read Posts in Radiotherapy This Week: June 28 - July 5

SBRT for Central and Ultra-Central Lung Tumors

Can ​Optimizing Pre-RT Dental Management via Jaw Dose Prediction

Implementing ESGO 2023 Guidelines for Adjuvant Radiotherapy in Vulvar Cancer

INTRAGO-II Finds No Survival Benefit From Intraoperative Radiotherapy in Newly Diagnosed Glioblastoma

10 Must-Read Posts in Radiotherapy This Week: June 21-28

OncoDaily TV
Daraxonrasib for Pancreatic Cancer: What’s Next?

Daraxonrasib for Pancreatic Cancer: What’s Next?

1000 doctors standing asco alan sandler

Why 1000 Doctors Gave This Cancer Drug A Standing Ovation?

Empowering Oncologists: Are Digital Literacy Tools Critically Important?

Empowering Oncologists: Are Digital Literacy Tools Critically Important?

ASCO

OncoDaily Highlights from ASCO 2026 Chicago, USA

Episode 17: Global Health Dialogues with Princess Dina and Eman Shannan

Episode 17: Global Health Dialogues with Princess Dina and Eman Shannan

Where You Live Shouldn't Dictate Your Cancer Survival: Dr. Benjamin Anderson

Where You Live Shouldn’t Dictate Your Cancer Survival: Dr. Benjamin Anderson

Investing in Cancer Care: Better Health, Stronger Economies: Herb Riband

Investing in Cancer Care: Better Health, Stronger Economies: Herb Riband

Kefah Mokbel

Kefah Mokbel: Can Diet Influence Cancer Risk and Outcomes?

Empowering Oncologists: How to make the most of your fellowship?

Empowering Oncologists: How to make the most of your fellowship?

STAMP Inhibitors Against CML: Prof. Timothy Hughes

STAMP Inhibitors Against CML: Prof. Timothy Hughes

Oncology's Greatest Threat: A System in Crisis

Oncology’s Greatest Threat: A System in Crisis

OncoDaily Grand Rounds at ASCO 2026: Sarcoma Edition: Highlights of the event

OncoDaily Grand Rounds at ASCO 2026: Sarcoma Edition: Highlights of the event

Not To Miss
ESMO GI 2026

20 Posts Not To Miss From ESMO GI 2026, Part 2

20 Posts Not To Miss From ESMO GI 2026, Part 1

Top Growing Medical Universities in Asia: 2026 Edition by BIGR

20 Posts Not To Miss From SIOP Asia Congress 2026

10 Essential Lung Cancer Posts You Can’t Miss This Week

Oncology Community Welcomes Two New FDA Approvals for Breast Cancer

15 Posts Not To Miss From ASCO Breakthrough 2026

OncoGrants
Global Ovarian Cancer Research Consortium AI Accelerator Grant — OCRA

Global Ovarian Cancer Research Consortium AI Accelerator Grant — OCRA

ACOG Foundation 2026 Request for Grant Proposals

ACOG Foundation 2026 Request for Grant Proposals

Clinical Trial Award — DoD OCRP

Clinical Trial Award — DoD OCRP

Ovarian Cancer Academy – Early-Career Investigator Award — DoD OCRP

Ovarian Cancer Academy – Early-Career Investigator Award — DoD OCRP

Investigator-Initiated Research Award — DoD Ovarian Cancer Research Program

Investigator-Initiated Research Award — DoD Ovarian Cancer Research Program

Kids Beating Cancer — John Voight Memorial Leukemia Research Grant

Kids Beating Cancer — John Voight Memorial Leukemia Research Grant

Oncologist near me
Oncologist Near Me

Oncologist Near Me – Gregory Kalemkerian: Advancing Lung Cancer Care, Research, and Education
Oncologist Near Me

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership
Oncologist Near Me

Oncologist Near Me – Paolo Tarantino: Shaping the Future of Breast Cancer Treatment
Oncologist Near Me

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care
Oncologist Near Me

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine
Oncologist Near Me

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology
Oncologist Near Me

Oncologist Near Me – Bishal Gyawali: Challenging the Status Quo in Global Oncology
Oncologist Near Me

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
Oncologist Near Me

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research
Oncologist Near Me

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

Cancer types
MCL Mantle cell lymphoma, BTK inhibitors

Mantle Cell Lymphoma (MCL): Revealing the Biology Beneath the Mantle and Modern Therapeutic Frontiers

Burkitt Lymphoma: Among the Fastest Growing Yet Most Curable Human Cancers

Diffuse Large B-Cell Lymphoma (DLBCL): Molecular Heterogeneity and Progress in Therapy

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Current Perspectives on an Ultra-Rare Malignancy

Richter Transformation (RT): When Chronic Lymphocytic Leukemia Turns Aggressive

Acute Myeloid Leukemia (AML) in 2026: The Current Landscape and Future Perspectives

Follicular Lymphoma (FL): Evolving Biology and Modern Therapeutic Paradigms

CancerWorld

Oncologists
Maite Gorostegui Obanos

Maite Gorostegui Obanos

Oncologists Location Barcelona, Spain
Tullio Golia D’Augè

Tullio Golia D’Augè

Oncologists Location Rome, Italy
Antonella Cammarota

Antonella Cammarota

Oncologists Location Milan, Italy
Juliet Lumati

Juliet Lumati

Oncologists Location Illinois, USA
Jalid Sehouli

Jalid Sehouli

Oncologists Location Berlin, Germany
Philip Kantoff

Philip Kantoff

Oncologists Location Boston, USA
Mariam Abuladze

Mariam Abuladze

Oncologists Location Tbilisi, Georgia
Mintu Mathew Abraham

Mintu Mathew Abraham

Oncologists Location Mumbai, India

Oncology Drugs
Sacituzumab Tirumotecan

Sacituzumab Tirumotecan: What Patients Should Know About This Emerging Cancer Treatment

Sacituzumab Tirumotecan: Clinical Development, Mechanism, and Emerging Role in Modern Oncology

Lurbinectedin: What Patients Should Know

Lurbinectedin in Oncology: Mechanism, Clinical Data, Evolving Role, and Future Directions

Bemarituzumab: What Patients with Gastric Cancer Should Know

Bemarituzumab: Uses in Cancer, Side Effects, Dosages, Expectations and More

GSK5764227 (HS-20093): A Novel B7-H3 Targeted Antibody–Drug Conjugate Under Clinical Investigation

OncoDaily Magazine

New Paper Alert
Rodrigo Lastra del Prado

Rodrigo Lastra del Prado: Benefits of Empathetic Oncologist Patient Communication

ICRA trial

The ICRA trial: Paclitaxel Plus Tremelimumab Shows Activity After Platinum and PD-(L)1 Therapy in Metastatic Urothelial Cancer

Screening - OncoDaily

A Unified Framework for Pre-Screening and Screening Tools in Oncology Clinical Trials 2026

Cardiovascular Disease

Prevention And Management Of Cardiovascular Disease In Adults With Cancer: IC-OS And MASCC Clinical Practice Statement

EORTC–ESTRO

Endpoints in Metastases Directed Therapy for Oligometastatic Cancer A Review and Consensus by the EORTC–ESTRO OligoCare Consortium

MONTBLANC Trial

MONTBLANC Trial Recruitment Completed: Triple Immunotherapy in Advanced HCC

OncoDaily Medical Journal

Lung Cancer

10.69690/ODMJ-001-0626-7958

Evaluation of Intra-Fractional Target Position Variation during Deep Inspiration Breath-Hold (DIBH) Sessions in Lung Stereotactic Body Radiotherapy (SBRT)
Original Research

Hematology

10.69690/ODMJ-001-0526-7344

Analysis of Mortality Factors in the Pediatric Hemato-Oncology Department of the Children's Hospital of Rabat, 2022-2023
Original Research

Radiation Oncology

10.69690/ODMJ-011-0526-7409

An Independent Read-Only Verification and Risk-Management System to Maintain Radiotherapy Safety During Oncology Information System Failure
Case Reports & Case Series

Cancer Care

10.69690/ODMJ-001-0426-7451

Distinct differences in the tumour-resident microbiome between early- and late-onset colorectal cancer
Original Research

Hematology

10.69690/odmj-012-0426-7512

Frailty, infections, and bispecific antibodies in multiple myeloma: redefining supportive care in the era of T-cell redirection
Commentaries

Oncology Nursing

10.69690/ODMJ-002-0426-7359

Barriers and Facilitators of Oral Nutritional Supplement Adherence in Cancer: A Systematic Review
Reviews

Hematology

10.69690/ODMJ-011-0426-7452

Double Dilemma: Managing a Sequential Lymphoma (Case Report)
Case Reports & Case Series

Hematology

10.69690/ODMJ-011-0426-7442

Outcome of Hematopoietic Stem Cell Transplantation in Pediatric Patients with Severe Aplastic Anemia and Multi-Drug Resistant Bacterial Infections - A Case Series
Case Reports & Case Series